Useful second-tier tests in expanded newborn screening of isovaleric acidemia and methylmalonic aciduria

Yosuke Shigematsu1, Ikue Hata, Go Tajima

  • 1Department of Health Science, Faculty of Medical Sciences, University of Fukui, Eiheiji-cho, Fukui, Japan. yosuke@u-fukui.ac.jp

Insights

Newborn screening for isovaleric acidemia (IVA) using acylcarnitine (C5) generated many false positives. A new test measuring isovalerylglycine (IVG) in dried blood spots accurately identified severe IVA cases and assessed disease severity.

Area of Science:

  • Biochemistry
  • Metabolic Disorders
  • Newborn Screening

Background:

  • Pivalate-generating antibiotics and low C5-acylcarnitine cutoff values in Japan led to numerous false positives in newborn screening for isovaleric acidemia (IVA).
  • Existing screening methods require refinement for accurate diagnosis and severity assessment of IVA and related metabolic disorders.

Purpose of the Study:

  • To develop and validate second-tier tests for accurate IVA diagnosis and severity assessment using dried blood spots (DBS).
  • To establish a reliable method for detecting methylmalonic aciduria (MMAU) and propionic acidemia.

Main Methods:

  • Developed a second-tier test measuring isovalerylglycine (IVG) levels in DBS with a cutoff of 0.5 nmol/ml.
  • Developed a gas chromatography/mass spectrometry (GC/MS) method to measure methylmalonic acid (MMA) levels in DBS.

Main Results:

  • The IVG test identified one severe IVA patient among 1,065 initial positive screens, avoiding unnecessary recalls.
  • Retrospective analysis showed decreased free carnitine and higher IVG than C5 levels in moderate to severe IVA patients.
  • MMAU patients exhibited significantly higher DBS MMA concentrations (24.2-321.9 nmol/ml) compared to controls (0.34 ± 0.11 nmol/ml).
  • High MMA levels in MMAU patients correlated with decreased free carnitine and mildly increased propionylcarnitine.

Conclusions:

  • Measuring IVG in DBS is an effective second-tier test for confirming IVA and evaluating its severity.
  • GC/MS measurement of DBS MMA provides valuable information for diagnosing MMAU and assessing its severity.
  • These refined methods improve the accuracy and efficiency of newborn screening for inherited metabolic disorders.

Related Concept Videos

Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
Serum Laboratory Studies, Stool Test, Breath Test01:30

Serum Laboratory Studies, Stool Test, Breath Test

Gastrointestinal (GI) diagnostic studies are pivotal in confirming, ruling out, diagnosing, or staging various diseases, including cancers. Following diagnosis, allocating time for discussions with the patient and providing informational resources is crucial. Diagnostic assessments of the GI tract often occur in outpatient settings like endoscopy suites or GI labs. Preparation for these tests may include dietary restrictions, fasting, liquid bowel preparations, laxatives, enemas, and the...
Amines to Sulfonamides: The Hinsberg Test01:23

Amines to Sulfonamides: The Hinsberg Test

The Hinsberg test is a method to identify primary, secondary and tertiary amines, named after its pioneer, Oscar Hinsberg. Here, amines are treated with benzenesulfonyl chloride, also known as the Hinsberg reagent, in the presence of an excess of aqueous base, followed by acidification. Based on the nature of the amines, different changes are observed.
Generally, a primary amine reacts with the Hinsberg reagent to produce an N-substituted benzenesulfonamide. The electron-withdrawing sulfonyl...
Diagnosing Acidosis and Alkalosis01:24

Diagnosing Acidosis and Alkalosis

Diagnosing acid-base imbalances involves systematically analyzing arterial blood samples, focusing on three key measurements: pH, bicarbonate (HCO3−) concentration, and carbon dioxide partial pressure (PCO2). This analysis follows a four-step process that helps identify the imbalance's underlying cause and nature.
First, the pH level is assessed to determine whether the blood pH is normal (7.35–7.45), low (acidosis), or high (alkalosis).
Next, the PCO2  and HCO3−  values are examined to...
Automated Microbial Diagnostics01:24

Automated Microbial Diagnostics

Automated diagnostic analyzers have transformed clinical microbiology by providing rapid and reliable methods for pathogen identification and antibiotic susceptibility testing. Among these systems, the Vitek 2 is widely used because it automates the traditionally labor-intensive processes of microbial identification (ID) and antibiotic susceptibility testing (AST), delivering standardized and timely results that are essential for effective patient care.Microbial Identification with ID CardsThe...
Serum Studies: Renal Function Tests01:24

Serum Studies: Renal Function Tests

Renal function tests are crucial for assessing kidney health, monitoring disease progression, and evaluating the kidneys' efficiency in waste elimination, fluid balance, and electrolyte regulation. These tests offer critical insights into kidney function, even though routine measurements may appear normal until there is a significant decline in the glomerular filtration rate or GFR. Typically, signs of kidney impairment only become evident when the GFR falls to about 50% of its normal level.